Tag Archives: Deutsche Bank

Financial Daily Dose 11.01.2019 | Top Story: Watching for the GM-strike Impact on the October Jobs Report

BY: Michael D. Reif | November 1, 2019

Jobs Report Friday again. Here’s what we’re watching, including the possibility of scary low numbers thanks to the only-recently-resolved GM strike – Bloomberg and NYTimes and WSJ A former chief of staff to WeWork co-founder Adam Neumann and a series of other women have filed gender discrimination claims against the company accusing it of what … Continue reading

Financial Daily Dose 10.31.2019 | Top Story: Fed Delivers Expected Interest Rate Cut

BY: Michael D. Reif | October 31, 2019

As universally expected, the Fed’s Open Market Committee delivered its third interest rate cut of 2019 yesterday, though it did so while signaling that it’s likely to pause before taking action again and “is now shifting into a more patient mode” – NYTimes and WSJ and Bloomberg Markets generally approved despite Chair Powell’s hints at … Continue reading

Financial Daily Dose 8.23.2019 | Top Story: Financial World Anxiously Awaits Fed Chair’s Jackson Hole Speech for Rate-Cut Clues

BY: Michael D. Reif | August 23, 2019

Jackson Hole’s beautiful this time of year. But that’s not why you’ll be hearing all about it today. Nope, more relevant for our purposes is the gathering there of top economists from around the world and the hotly anticipated comments this morning from Fed Chair Powell, who must once again dance on a tightrope while … Continue reading

Financial Daily Dose 7.24.2019 | Top Story: DOJ Launches Big Tech Antitrust Probe

BY: Michael D. Reif | July 24, 2019

The announcement itself isn’t a shock, but given the potential players, it’s headline-worthy anyway: the DOJ announced yesterday that it’s officially opening an antitrust probe into Big Tech companies and “whether they had acted to reduce competition” as they amassed market power – NYTimes and WSJ and Bloomberg and MarketWatch US regulators are likely to … Continue reading

Financial Daily Dose 7.11.2019 | Top Story: Fed Chair Primes Markets for July Rate Cut

BY: Michael D. Reif | July 11, 2019

The big takeaway from Day 1 of Fed Chair Powell’s Congressional testimony is that a July rate cut is still definitely on the table, despite last week’s strong US jobs numbers.  As the Times puts it, “That the Fed is considering a rate cut a moment when the United States economy is strong and job … Continue reading

Financial Daily Dose 7.9.2019 | Top Story: Deutsche Bank Cuts 18,000 Jobs Globally

BY: Michael D. Reif | July 9, 2019

Lots more details on what turned out to be something of a bloodbath for Deutsche Bank employees around the world, with the bank starting to make good yesterday on its plans to cut nearly 18,000 employees worldwide – NYTimes and WSJ and Bloomberg and Marketplace and Law360 All of which is really a Deutsche Bank … Continue reading

Financial Daily Dose 7.8.2019 | Top Story: Friday’s Solid Jobs Report Prompts Rate-Cut Concerns

BY: Michael D. Reif | July 8, 2019

We managed to miss Jobs Report Friday because of the holiday break, so here’s the lowdown on a very strong set of numbers—224,000 jobs added—and the seemingly incongruous market reaction to the good news (it’s all about the Fed and interest rates, my friends) – NYTimes and WSJ and Bloomberg and MarketWatch and Marketplace Turkey’s … Continue reading

Financial Daily Dose 7.1.2019 | Top Story: US and China Pledge to Resume Trade Talks

BY: Michael D. Reif | July 1, 2019

The US and China agreed to resume trade talks after a  7-week hiatus, “averting for now an escalation of their multibillion-dollar tariff war that has roiled global markets and threatened the future of the world’s two largest economies.” An easing of the White House’s Huawei restrictions and China’s agreement to “buy a ‘tremendous amount’ of … Continue reading

Financial Daily Dose 6.25.2019 | Top Story: Allergan and AbbVie Combine Forces in $63 Billion Deal

BY: Michael D. Reif | June 25, 2019

Massive pharma news to start the day, with AbbVie announcing that it’s reached a deal to buy Allergan for roughly $63 billion. The tie-up is seen as giving AbbVie a “dominant position in the $8 billion-plus market for Botox and other beauty drugs” is it “braces for the end of patent protection for the world’s … Continue reading

Financial Daily Dose 6.11.2019 | Top Story: Opioid Maker Insys Files for Chapter 11 Protection

BY: Michael D. Reif | June 11, 2019

Opioid manufacturer Insys Therapeutics, which just last week agreed to pay $225 million to “settle a federal investigation into the marketing practices for its powerful fentanyl painkiller,” has filed for bankruptcy protection, announcing that it will continue operating while putting together a plan to pay its creditors – NYTimes and WSJ and Law360 More details … Continue reading